학술논문

Can some ER+/HER2+patients be safely spared from treatment with chemotherapy plus herceptin?
Document Type
Journal
Source
CANCER RESEARCH; FEB 2020, 80 4, 3p. Supplement: S
Subject
Language
English
ISSN
15387445